Kolexia
Bechade Dominique Gastro-entérologie
Bechade Dominique
Gastro-entérologie
Institut Bergonié
Bordeaux, France
68 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Adénocarcinome Métastase tumorale Tumeurs du poumon Tumeurs du pancréas Tumeurs du foie Carcinomes Tumeurs du péritoine Lymphadénopathie

Collaborateurs

Voir plus
Fonck-Frayssinet Marianne
Fonck-Frayssinet Marianne
Institut Bergonié, Bordeaux, France
Desolneux Gregoire
Desolneux Gregoire
Institut Bergonié, Bordeaux, France
Becouarn Yves
Becouarn Yves
Institut Bergonié, Bordeaux, France
Evrard Serge
Evrard Serge
Institut Bergonié, Bordeaux, France

Industries

Voir plus
MSD
2 collaboration(s)
Dernière en 2023
Mylan Medical
2 collaboration(s)
Dernière en 2021
Pierre Fabre
1 collaboration(s)
Dernière en 2022
Boston Scientific
1 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Echoendoscopic ultrasound pancreatic adenocarcinoma diagnosis and theranostic approach: should mutation research be recommended in everyday practice?
Therapeutic advances in gastroenterology   17 janvier 2024
Radiofrequency ablation of lung metastases of colorectal cancer: could early radiomics analysis of the ablation zone help detect local tumor progression?
The British journal of radiology   17 avril 2023
OMEGA: Phase II Study Evaluating the Efficacy and Tolerance to Chemotherapy With 5-fluorouracil, Folinic Acid, Irinotecan and Bevacizumab as First-line Treatment in Patients With Metastatic Colorectal Cancer
Essai Clinique (Institut Bergonié)   28 octobre 2022
Correction to: Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study.
British journal of cancer   14 mai 2022
Diagnostic accuracy and clinical impact of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in Positron Emission Tomography - Computed Tomography (PET-CT)-positive mediastinal lymphadenopathies in patients with thoracic or extra-thoracic malignancies.
Clinics and research in hepatology and gastroenterology   25 mars 2022
Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study.
British journal of cancer   29 janvier 2022
Radiomics complements clinical, radiological, and technical features to assess local control of colorectal cancer lung metastases treated with radiofrequency ablation.
European radiology   05 mai 2021
APOGEE: Feasibility Study on the Contribution of Guided Puncture With Echoendoscopy in Evaluation of Hypermetabolic Lymphadenopathy Mediastinum Lower, Rear and Middle, Detected in PET-CT to 18 FDG (PET)
Essai Clinique (Institut Bergonié)   26 avril 2021
PD-6 Gemcitabine + nab-paclitaxel or gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: A population-based, multicenter AGEO study
ESMO 22nd World Congress on Gastrointestinal Cancer, 2020 Virtual - 1 - 4 July 2020   01 juillet 2020
Caractérisation d’un foyer d’hyperfixation intra pancréatique en TEP-TDM 68Ga-DOTATOC par IRM et scintigraphie aux globules rouges-altérés
6èmes Journées Francophones de Médecine Nucléaire - Paris   01 mars 2020